I Sivin

Summary

Affiliation: The Rockefeller University
Country: USA

Publications

  1. ncbi Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants
    Irving Sivin
    Population Council, Center for Biomedical Research, New York, New York 10021, USA
    Drug Saf 26:303-35. 2003
  2. ncbi A reply to D. Wildemeersch's erring reply. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system
    Irving Sivin
    Contraception 71:315. 2005
  3. ncbi Levonorgestrel capsule implants in the United States: a 5-year study
    I Sivin
    Center for Biomedical Research, Population Council, New York, New York, 10021, USA
    Obstet Gynecol 92:337-44. 1998
  4. ncbi Utility and drawbacks of continuous use of a copper T IUD for 20 years
    Irving Sivin
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 75:S70-5. 2007
  5. ncbi Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial
    Irving Sivin
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 71:122-9. 2005
  6. ncbi Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women
    Irving Sivin
    Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10021, USA
    Contraception 69:137-44. 2004
  7. ncbi State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices
    Irving Sivin
    Population Council, New York, NY10065, USA
    Eur J Contracept Reprod Health Care 15:96-112. 2010
  8. ncbi Recent developments in contraceptive implants at the Population Council
    Irving Sivin
    Population Council, Center for Biomedical Research, New York, NY, USA
    Contraception 65:113-9. 2002
  9. ncbi Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants
    I Sivin
    Center for Biomedical Research, Population Council, New York, NY, USA
    Contraception 64:43-9. 2001
  10. ncbi Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen
    Regine L Sitruk-Ware
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 75:430-7. 2007

Collaborators

Detail Information

Publications17

  1. ncbi Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants
    Irving Sivin
    Population Council, Center for Biomedical Research, New York, New York 10021, USA
    Drug Saf 26:303-35. 2003
    ....
  2. ncbi A reply to D. Wildemeersch's erring reply. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system
    Irving Sivin
    Contraception 71:315. 2005
  3. ncbi Levonorgestrel capsule implants in the United States: a 5-year study
    I Sivin
    Center for Biomedical Research, Population Council, New York, New York, 10021, USA
    Obstet Gynecol 92:337-44. 1998
    ....
  4. ncbi Utility and drawbacks of continuous use of a copper T IUD for 20 years
    Irving Sivin
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 75:S70-5. 2007
    ..Those who do so would find considerable protection against pregnancy and reasonable economic benefits in continuing to use the same device...
  5. ncbi Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial
    Irving Sivin
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 71:122-9. 2005
    ..Clinical performance and adverse event profiles indicate that each of these 1-year NES/EE rings, used on a 21-day-in and 7-day-out regimen, provided women effective, acceptable and safe long-acting contraception under their own control...
  6. ncbi Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women
    Irving Sivin
    Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10021, USA
    Contraception 69:137-44. 2004
    ..A single NES implant appears to provide acceptable contraception for women...
  7. ncbi State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices
    Irving Sivin
    Population Council, New York, NY10065, USA
    Eur J Contracept Reprod Health Care 15:96-112. 2010
    ..For our literature search we used Medline, Popline and Cochrane Library data bases, Google search, our personal files, and the references contained in articles in our files...
  8. ncbi Recent developments in contraceptive implants at the Population Council
    Irving Sivin
    Population Council, Center for Biomedical Research, New York, NY, USA
    Contraception 65:113-9. 2002
    ..The status and rationale of studies of a new Nestorone-releasing, single implant developed by the Population Council for a period of use of 2 years are presented...
  9. ncbi Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants
    I Sivin
    Center for Biomedical Research, Population Council, New York, NY, USA
    Contraception 64:43-9. 2001
    ....
  10. ncbi Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen
    Regine L Sitruk-Ware
    Center for Biomedical Research, Population Council, New York, NY 10021, USA
    Contraception 75:430-7. 2007
    ..We also investigated the effect of delivery route, which is known to modify the hepatic effects of estradiol, but has not been widely studied with EE...
  11. ncbi Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables
    Mandana Rad
    Centre for Human Drug Research, Leiden, The Netherlands
    Am J Obstet Gynecol 195:72-7. 2006
    ..This study aimed to compare the effects on hemostasis variables of a contraceptive vaginal ring with those of an oral contraceptive...
  12. ncbi Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen
    Edith Weisberg
    Sydney Center for Reproductive Health Research, Research Division of FPA Health, NSW 2131, Australia
    Contraception 72:46-52. 2005
    ..Ring removal times were signaled by menstrual events. Bleeding patterns, adverse events, patterns of use and continuation rates were the principal parameters evaluated...
  13. ncbi Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen
    Ian S Fraser
    Department of Obstetrics and Gynaecology, University of Sydney, Sydney NSW 2006, Australia
    Contraception 72:40-5. 2005
    ....
  14. ncbi One-year gross cumulative discontinuation rates are not the rates published by Wildemeersch et al
    Irving Sivin
    Contraception 73:315-6; author reply 316-7. 2006
  15. ncbi Failing in analysis of the performance of the gynefix 200 intrauterine system
    Irving Sivin
    Contraception 70:353-4; author reply 354-5. 2004
  16. ncbi Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women"
    Irving Sivin
    Contraception 69:259-60. 2004
  17. ncbi A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men
    Sigrid von Eckardstein
    Institute of Reproductive Medicine, University of Munster, Munster, Germany
    J Clin Endocrinol Metab 88:5232-9. 2003
    ....